ArticleJAAD international2026
Risk factors for the development of acral melanoma: A multi-institutional, retrospective cohort study.
Article in JAAD international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Acral melanoma (AM) is a rare but aggressive melanoma subtype. Understanding demographic and clinical risk factors is essential for advancing prevention and early detection. Objectives: To identify demographic and clinical risk factors for AM compared with nonmelanoma and cutaneous melanoma (CM) controls. Methods: This multi-institutional retrospective cohort study of patients evaluated at the Mass General Brigham and Dana-Farber Cancer Institute. Three cohorts were created via manual curation of pathology reports: AM cases, nonmelanoma controls, and CM controls. AM patients were matched 1:4 to controls based on pre/postindex follow-up time and dermatologic care history. Multivariable logistic regression and structural equation modeling assessed direct and indirect pathways linking sex, actinic keratoses, and melanoma subtype. Results: A total of 2115 patients were analyzed. AM patients were more often female and disproportionately Asian or Black compared with both controls. Relative to non-melanoma controls, AM was associated with female sex, Asian, or Black race, leukemia/lymphoma, nonmelanoma skin cancer, and actinic keratoses. Similar findings were present against CM controls. Conclusions: AM risk is associated with female sex, Asian or Black race, and select prior malignancies. Findings demonstrate an association between markers of UV exposure (actinic keratoses) and AM risk, though significantly weaker than in CM. These insights may guide prevention, risk stratification, and mechanistic research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.